Physician

Christel Cary Malinski, MD

According to 2025 Medicare claims, Christel Malinski, MD (NPI: 1013231034) practices dermatology in the Slidell-Mandeville-Covington, LA market, with the plurality of this provider's patient population coming from St. Tammany, LA. This provider's primary affiliated billing organization is MALINSKI DERMATOLOGY (NPI: 1598380321; TIN: 851258862) and primary practice location at 70445-3499.

Malinski's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 312 traditional Medicare patients, billed 4,641 HCPCS/CPT codes, and received $333,912 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 778 prescription claims across 284 beneficiaries totaling $240,684 in drug costs, led by Clobetasol Propionate (Clobetasol Propionate). Open Payments data shows 27 records totaling $4,805. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $142,819 to $333,912. Similarly, Part D prescription costs have risen steadily, from $66,863 to $240,684. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$167K$334K2015 Medicare payment: $142,819 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $154,325 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $130,780 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $125,788 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $198,044 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $128,626 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $68,864 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $274,689 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $280,633 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $333,912 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153773,305$142,819
20164143,623$154,325
20173493,269$130,780
20182822,517$125,788
20193002,750$198,044
20202922,282$128,626
20211571,492$68,864
20222153,680$274,689
20232493,976$280,633
20243124,641$333,912

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$120K$241K2015 Drug cost: $66,863 (USD; Tot_Drug_Cst)2016 Drug cost: $99,047 (USD; Tot_Drug_Cst)2017 Drug cost: $143,195 (USD; Tot_Drug_Cst)2018 Drug cost: $79,990 (USD; Tot_Drug_Cst)2019 Drug cost: $105,868 (USD; Tot_Drug_Cst)2020 Drug cost: $140,029 (USD; Tot_Drug_Cst)2021 Drug cost: $28,958 (USD; Tot_Drug_Cst)2022 Drug cost: $190,925 (USD; Tot_Drug_Cst)2023 Drug cost: $214,895 (USD; Tot_Drug_Cst)2024 Drug cost: $240,684 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015262690$66,863
2016292791$99,047
2017298765$143,195
2018287770$79,990
2019320918$105,868
2020252711$140,029
2021142372$28,958
2022195512$190,925
2023245786$214,895
2024284778$240,684

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more261526$84
17110Destruction of skin growth, 1-14 growths100129$72
11102Biopsy of related skin growth, first growth145190$60
17000Destruction of precancer skin growth, 1 growth167273$33
17003Destruction of precancer skin growth, 2-14 growths133982$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Clobetasol PropionateClobetasol Propionate852,140$2,580
KetoconazoleKetoconazole1744,951$2,312
ValacyclovirValacyclovir Hcl30950$1,223
Triamcinolone AcetonideTriamcinolone Acetonide651,643$781
FluconazoleFluconazole714,425$591

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.27$4,805Galderma Laboratories, L.P.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Christel Cary Malinski, MD?

Tedicare shows public-source Medicare data for Christel Cary Malinski, MD (NPI 1013231034), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christel Cary Malinski, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Christel Cary Malinski, MD?

Christel Cary Malinski, MD is linked to MALINSKI DERMATOLOGY (billing NPI 1598380321) in the available physician profile data.

Does Christel Cary Malinski, MD have Open Payments data?

Christel Cary Malinski, MD has 27 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.